{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:27:55Z","timestamp":1783024075109,"version":"3.54.6"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>A 69-year-old man diagnosed with sarcomatoid pleural mesothelioma received 3 cycles of nivolumab with 2 cycles of ipilimumab. Treatment was terminated after the patient developed colitis\u2014an immune-related adverse event (irAE). High-dose prednisolone was initiated. Between 1 and 2 weeks later, the patient underwent FDG- and FAPI PET\/CT, both exhibiting prominent, diffuse uptake in the thyroid gland. Biochemistry just before the scans revealed hypothyroidism with further derangement in the following weeks. The patient was diagnosed with irAE thyroiditis. FAPI uptake in chronic thyroiditis has been previously described, whereas uptake in irAE thyroiditis has only been reported once.<\/jats:p>","DOI":"10.1097\/rlu.0000000000006444","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:03:37Z","timestamp":1775657017000},"page":"e736-e738","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Thyroiditis Induced by Immune Checkpoint Inhibitors Exhibits High [68Ga]Ga-FAPI-46 and [18F]FDG Uptake on PET\/CT"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2397-0961","authenticated-orcid":false,"given":"Anne H.","family":"Thostrup","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Bentestuen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor L.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika M.","family":"Szejniuk","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University"},{"name":"Department of Oncology and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle D.","family":"Zacho","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/thy.2018.0116","article-title":"Immune-related thyroiditis with immune checkpoint inhibitors","volume":"28","author":"Iyer","year":"2018","journal-title":"Thyroid"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2967\/jnmt.117.204933","article-title":"(18)F-FDG PET\/CT can predict development of thyroiditis due to immunotherapy for lung cancer","volume":"46","author":"Eshghi","year":"2018","journal-title":"J Nucl Med Technol"},{"key":"R5-20260702","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162651","article-title":"Endocrine adverse events induced by cancer treatments: the role of (18)F-fluorodeoxyglucose positron emission tomography","volume":"17","author":"Giovanella","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJMra1901214","article-title":"Drug effects on the thyroid","volume":"381","author":"Burch","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20260702","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101023","article-title":"New frontiers in cancer imaging and therapy based on radiolabeled fibroblast activation protein inhibitors: a rational review and current progress","volume":"14","author":"Imlimthan","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy.","volume":"33","author":"Ragusa","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"782231","DOI":"10.3389\/fmed.2021.782231","article-title":"Clinical significance of diffusely increased uptake of (68)Ga-FAPI in thyroid gland","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-024-01129-y","article-title":"[(68)Ga]Ga-FAPI versus 2-[(18)F]FDG PET\/CT in patients with autoimmune thyroiditis: a case control study","volume":"14","author":"Pabst","year":"2024","journal-title":"EJNMMI Res"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1007\/s00259-021-05373-5","article-title":"(68)Ga-FAPI-46 and (18)F-FDG PET\/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors","volume":"48","author":"Hotta","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:10:36Z","timestamp":1783023036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006444"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006444","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"2026-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}